Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Current Assets (2020 - 2026)

IceCure Medical has reported Current Assets over the past 7 years, most recently at $12.1 million for Q1 2026.

  • For Q1 2026, Current Assets changed N/A year-over-year to $12.1 million; the TTM value through Mar 2026 reached $12.1 million, changed N/A, while the annual FY2025 figure was $12.6 million, 17.21% up from the prior year.
  • Current Assets was $12.1 million for Q1 2026 at IceCure Medical, down from $12.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $28.1 million in Q4 2022 and bottomed at $10.8 million in Q4 2024.
  • The 5-year median for Current Assets is $12.6 million (2025), against an average of $15.6 million.
  • Year-over-year, Current Assets tumbled 49.58% in 2023 and then rose 17.21% in 2025.
  • Over 5 years, Current Assets stood at $28.1 million in 2022, then tumbled by 49.58% to $14.2 million in 2023, then fell by 24.18% to $10.8 million in 2024, then grew by 17.21% to $12.6 million in 2025, then dropped by 3.82% to $12.1 million in 2026.
  • The last three reported values for Current Assets were $12.1 million (Q1 2026), $12.6 million (Q4 2025), and $10.8 million (Q4 2024) per Business Quant data.